Navigation Links
Acclaimed Author Lionel Shriver Supports Mesothelioma Awareness Day
Date:8/25/2014

Alexandria, VA (PRWEB) August 25, 2014

The Mesothelioma Applied Research Foundation (Meso Foundation) released today a video of award-winning author, Lionel Shriver, in which Ms. Shriver urges viewers to observe September 26th as Mesothelioma Awareness Day. The video can be watched on the Meso Foundation’s YouTube channel.

“Several years ago, one of my closest friends, was diagnosed with mesothelioma,” says Ms. Shriver in the video. “Her experience of living with the disease, and ultimately dying from it, moved me to write my tenth novel, ‘So Much for That.’”

“So Much for That” is a novel that tackles the complicated topic of healthcare in the United States, through the experience of a mesothelioma patient and her family.

In the video, viewers are urged to visit the organization’s website, curemeso.org, to learn more about Mesothelioma Awareness Day.

Ms. Shriver is best known as the author of the award-winning novel “We Need to Talk About Kevin,” and “Big Brother.”

Mesothelioma Awareness Day is a grassroots movement established in 2004 by volunteers of the Meso Foundation with the goal of bringing more attention and funding to this historically-neglected cancer.

“On behalf of the mesothelioma community, I am infinitely grateful to Ms. Shriver for her help in raising awareness,” said nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer.

“More awareness of this disease and the consequent increased funding for research, education, support, and advocacy is exactly what is needed to help us save lives,” added Ms. Hesdorffer.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/2014/08/prweb12118242.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. CVS Caremark Adds New, Natural Acclaimed Hair Care Line to its Beauty Roster
2. Oregon's Most Acclaimed Medical Marijuana "Canna Kitchen" Whips Up Smokeless Remedies for Albany OMMP Patients
3. Acclaimed 9/11 Photographer Gary Suson to Conduct 'Final' Press Interviews
4. Edward J. Bergman, New Jersey's Highly Acclaimed Mediator, Joins Leading Website Mediation.com
5. Patient Advocate for CancerConnect.com and Acclaimed Writer, Jamie Reno, Delivers Devastating News of Lifesaving Cancer Drug's Discontinuation
6. Acclaimed Fitness Business Consultant Shows Personal Trainers How to Grow a Fitness Business with Search Engine Optimization
7. Nationally Acclaimed Addictions Specialist Dan Cronin Joins Journey Malibu - The Leader in One-on-One Treatment
8. Kick-Start Your Weight Loss Today and Get a Massive 15-Percent Off the Acclaimed Pure Garcinia Cambogia Extract; Only While Stocks Last
9. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
10. Living Well Medical, a Top NYC Medical Facility, Welcomes Acclaimed Orthopedist Dr. Randall Victor Ehrlich, M.D.
11. Acclaimed Texas Surgeon Offers Hope through Expertise in Erb’s Palsy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: